middle.news
ECS Botanics Achieves Positive EBITDA with Strong Branded Sales and Global Expansion
8:31am on Friday 28th of August, 2026 AEST
•
Healthcare
Read Story
ECS Botanics Achieves Positive EBITDA with Strong Branded Sales and Global Expansion
8:31am on Friday 28th of August, 2026 AEST
Key Points
10% revenue growth to $21.4 million
EBITDA turns positive at $0.6 million
Branded B2C sales double to $13.7 million
International launches in Germany, New Zealand, Poland
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ecs Botanics (ASX:ECS)
OPEN ARTICLE